Kremlin calls Sharapova's doping failure an isolated case

Image
AFP Moscow
Last Updated : Mar 09 2016 | 5:43 PM IST
The Kremlin today expressed regret over the country's tennis star Maria Sharapova testing positive for a banned drug at the Australian Open but insisted this was an isolated case.
"Of course the Kremlin knows (about the case), the sports ministry gives us information," Kremlin press spokesman Dmitry Peskov told journalists.
"We regret this, but at the same time this situation should not be projected onto the whole of Russian sport.
"The situation should not be presented in such a way that it somehow throws a shadow onto Russian sport, on the magnificent achievements of our athletes."
"We're talking about individual athletes, individual cases."
Sharapova confessed Monday that she had tested positive for Meldonium, a drug she said she had been taking since 2006 but that was only added to the banned list this year by the World Anti-Doping Agency (WADA).
The former world number one said a change in the WADA's banned list for 2016 led to an inadvertent violation, for which she will be "provisionally suspended" by the International Tennis Federation.
Sharapova said she originally began taking Meldonium for a variety of symptoms, including a tendency to become ill often, an irregular EKG heart test and a family history of diabetes.
Peskov meanwhile added that Russia's President Vladimir Putin has previously urged the sports officials to look at each doping case "as openly as possible and in full cooperation with the relevant international structures."
"We are convinced it will be the same way this time," Peskov said, adding he condemned any attempt to make the doping case about politics.
"As before we are convinced and consistent supporters of the idea that sport should stay outside politics," Peskov said.
"Attempts to politicise sport, to make sport a political instrument to achieve some aim or other are destructive for sport, for international sport, and are unacceptable and unforgivable," he said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 09 2016 | 5:43 PM IST

Next Story